These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 24857402)

  • 21. A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.
    Sakthong P; Munpan W
    Appl Health Econ Health Policy; 2017 Oct; 15(5):669-679. PubMed ID: 28290106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population.
    Kangwanrattanakul K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):765-774. PubMed ID: 32981380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients.
    Zhang F; Yang Y; Huang T; Zhang Y; Zhao L; Li S
    Int J Rheum Dis; 2018 Jun; 21(6):1185-1192. PubMed ID: 27463704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness.
    Franklin M; Enrique A; Palacios J; Richards D
    Qual Life Res; 2021 Sep; 30(9):2633-2647. PubMed ID: 33835414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes.
    Mulhern B; Meadows K
    Health Qual Life Outcomes; 2014 Mar; 12():42. PubMed ID: 24661350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.
    Mulhern B; Pink J; Rowen D; Borghs S; Butt T; Hughes D; Marson A; Brazier J
    Value Health; 2017 Apr; 20(4):687-693. PubMed ID: 28408012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The psychometric performance of generic preference-based measures for patients with pressure ulcers.
    Palfreyman S; Mulhern B
    Health Qual Life Outcomes; 2015 Aug; 13():117. PubMed ID: 26231179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
    Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
    Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of patient-reported outcome measures in individuals following acute whiplash injury.
    Pink J; Petrou S; Williamson E; Williams M; Lamb SE
    Health Qual Life Outcomes; 2014 Mar; 12():38. PubMed ID: 24625124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.
    Bjerk M; Brovold T; Davis JC; Bergland A
    Qual Life Res; 2019 Dec; 28(12):3187-3195. PubMed ID: 31364036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
    Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
    Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric Performance of the SF-6D Quality of Life Measure in an Outpatient Population with Bipolar Disorder.
    Pogue YZ; Lavelle TA; Hodgkin D; Sylvia L; Ritter G; Nierenberg A
    J Ment Health Policy Econ; 2022 Dec; 25(4):143-150. PubMed ID: 36535912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping between the Roland Morris Questionnaire and generic preference-based measures.
    Khan KA; Madan J; Petrou S; Lamb SE
    Value Health; 2014 Sep; 17(6):686-95. PubMed ID: 25236992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putting the 'Q' in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures.
    Mann R; Gilbody S; Richards D
    Soc Psychiatry Psychiatr Epidemiol; 2009 Jul; 44(7):569-78. PubMed ID: 19011721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.
    Davis JC; Liu-Ambrose T; Khan KM; Robertson MC; Marra CA
    Osteoporos Int; 2012 Jul; 23(7):1849-57. PubMed ID: 21909728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.